Returns Breakdown
| Return on Assets | (0.16) | |
| Return on Equity | (0.18) | |
| Return Capital | (1.73) | |
| Return on Sales | (0.34) |
What can we learn from NeuroMetrix (USA Stocks:NURO) recent price fluctuation
 | By Gabriel Shpitalnik | Macroaxis Story |
NeuroMetrix Asset Turnover is very stable at the moment as compared to the past year. NeuroMetrix reported last year Asset Turnover of 0.55. As of 22nd of February 2023, Book Value per Share is likely to grow to 3.23, while Average Assets are likely to drop about 13.3 M. The rationale for this perspective is to give insiders our take on NeuroMetrix future value. We will focus on the reasons why it could be a game-changer for NeuroMetrix insiders.
Macroaxis uses a strict editorial review process to publish stories and blog posts. Our publishers support our company and may receive a small commission when the partner links or references are utilized. Commissions do not affect the opinions or evaluations of our editorial team. The information our editors and media partners deliver is confidential and licensed for your sole use as a Macroaxis user. We reserve all rights to the content of this article, and therefore copying or distributing this story in whole or in part is strictly prohibited.
Reviewed by Michael Smolkin
NeuroMetrix has a performance score of 3 on a scale of 0 to 100. The company secures a Beta (Market Risk) of 0.2611, which conveys not very significant fluctuations relative to the market. Let's try to break down what NeuroMetrix's beta means in this case. As returns on the market increase, NeuroMetrix returns are expected to increase less than the market. However, during the bear market, the loss on holding NeuroMetrix will be expected to be smaller as well. Although it is important to respect NeuroMetrix price patterns, it is better to be realistic regarding the information on the equity's historical price patterns. The philosophy towards estimating future performance of any stock is to evaluate the business as a whole together with its past performance, including all available fundamental and technical indicators. By analyzing NeuroMetrix technical indicators, you can presently evaluate if the expected return of 0.14% will be sustainable into the future. NeuroMetrix right now secures a risk of 3.3%. Please verify NeuroMetrix sortino ratio, semi variance, as well as the relationship between the Semi Variance and rate of daily change to decide if NeuroMetrix will be following its current price movements.
There are currently many different techniques concerning forecasting the market as a whole as well as predicting future values of individual securities such as NeuroMetrix. Regardless of method or technology, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Predictive Modules for NeuroMetrix
How important is NeuroMetrix's Liquidity
NeuroMetrix financial leverage refers to using borrowed capital as a funding source to finance NeuroMetrix ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. NeuroMetrix financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to NeuroMetrix's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of NeuroMetrix's financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the breakdown between NeuroMetrix's total debt and its cash.
NeuroMetrix Gross Profit
NeuroMetrix Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing NeuroMetrix previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show NeuroMetrix Gross Profit growth over the last 10 years. Please check NeuroMetrix's gross profit and other fundamental indicators for more details.
A Deeper Perspective
NeuroMetrix shows above-average downside volatility for the selected time horizon. We advise investors to inspect NeuroMetrix further and ensure that all market timing and asset allocation strategies are consistent with the estimation of NeuroMetrix future alpha. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure NeuroMetrix's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact NeuroMetrix's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Gabriel Shpitalnik do not own shares of NeuroMetrix. Please refer to our Terms of Use for any information regarding our disclosure principles.